【摘要】 目的分析盐酸氨溴索治疗慢性支气管炎急性发作的效果。方法方便选取2017年1月—2018年1月该院收治的慢性支气管炎急性发作患者86例,将其按照随机法分为观察组和对照组,每组43例,观察组患者使用盐酸氨溴索治疗,对照组患者仅接受常规治疗,观察并对比两组患者的治疗效果。结果观察组患者治疗有效率为95.35%,明显高于对照组的76.74%(χ~2=8.988,P<0.05),治疗后,观察组患者的相关身体指标[PaO2(75.39±8.32)mmHg,PaCO2(40.61±6.43)mmHg]改善情况优于对照组的[PaO2(70.59±9.26)mmHg,PaCO2(50.17±5.23)mmHg],差异有统计学意义(t=19.82、19.38,P<0.05)。结论盐酸氨溴索治疗慢性支气管炎急性发作能够很好的纠正患者的症状,促进患者健康的恢复,临床应用效果良好,值得推广使用。更多还原

【Abstract】 Objective To analyze the effect of ambroxol hydrochloride in the treatment of acute exacerbation of chronic bronchitis. Methods Eighty-six patients with acute exacerbation of chronic bronchitis admitted to the hospital from January2017 to January 2018 were convenient selected and enrolled. The patients were randomly divided into observation group and control group, with 43 cases in each group. The observation group used ambroxol hydrochloride treatment, the control group received only conventional treatment, and the therapeutic effects of the two groups were observed and compared. Results The effective rate was 95.35% in the observation group, which was significantly higher than 76.74% in the control group(χ~2=8.988,P<0.05). After treatment, the relevant body parameters of the observation group [PaO2(75.39±8.32)mmHg,Pa CO2(40.61±6.43) mmHg] improvement was better than that of the control group [PaO2(70.59±9.26) mmHg, PaCO2(50.17±5.23) mmHg], the difference was statistically significant(t =19.82, 19.38,P <0.05). Conclusion Ambroxol hydrochloride treatment of acute exacerbation of chronic bronchitis can well correct the symptoms of patients and promote the recovery of patients’ health. The clinical application effect is good and worthy of promotion.更多还原